Covered recipient · General Payments record
SIDHARTHA SINGH TULACHAN
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$913.54
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $609.00 | 31 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $365.76 | 21 |
| Takeda Pharmaceuticals U.S.A., Inc. | $100.83 | 2 |
| Gilead Sciences, Inc. | $63.88 | 3 |
| Celgene Corporation | $33.39 | 2 |
| PFIZER INC. | $30.01 | 2 |
| INTERCEPT PHARMACEUTICALS, INC. | $15.13 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.39 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106251549 | CMS |
| ABBVIE INC. | $10.95 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106251551 | CMS |
| ABBVIE INC. | $23.53 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106251553 | CMS |
| ABBVIE INC. | $26.78 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106251555 | CMS |
| ABBVIE INC. | $25.53 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106251557 | CMS |
| ABBVIE INC. | $20.57 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106251559 | CMS |
| ABBVIE INC. | $9.82 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106251561 | CMS |
| ABBVIE INC. | $22.35 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106251563 | CMS |
| ABBVIE INC. | $16.36 | 06/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106251565 | CMS |
| ABBVIE INC. | $18.23 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106251567 | CMS |
| ABBVIE INC. | $11.11 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106251569 | CMS |
| ABBVIE INC. | $23.77 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106251571 | CMS |
| ABBVIE INC. | $8.42 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106251573 | CMS |
| ABBVIE INC. | $19.48 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106251575 | CMS |
| ABBVIE INC. | $9.11 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106251577 | CMS |
| ABBVIE INC. | $20.97 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106251579 | CMS |
| ABBVIE INC. | $7.70 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106251581 | CMS |
| ABBVIE INC. | $4.58 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106251583 | CMS |
| ABBVIE INC. | $25.11 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106251585 | CMS |
| ABBVIE INC. | $23.37 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106251587 | CMS |
| ABBVIE INC. | $11.63 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106251589 | CMS |
| Celgene Corporation | $19.46 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101085425 | CMS |
| Celgene Corporation | $13.93 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101085433 | CMS |
| Gilead Sciences, Inc. | $26.08 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133788097 | CMS |
| Gilead Sciences, Inc. | $17.91 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133788099 | CMS |
| Gilead Sciences, Inc. | $19.89 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133788101 | CMS |
| Intercept Pharmaceuticals, Inc. | $15.13 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113642847 | CMS |
| PFIZER INC. | $14.11 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132052582 | CMS |
| PFIZER INC. | $15.90 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132069171 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $50.01 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137689866 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $50.82 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137689868 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.